Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 307

1.

An evaluation of fulvestrant for the treatment of metastatic breast cancer.

Soleja M, Raj GV, Unni N.

Expert Opin Pharmacother. 2019 Oct;20(15):1819-1829. doi: 10.1080/14656566.2019.1651293. Epub 2019 Sep 5.

PMID:
31486688
2.

Biomarkers for platinum sensitivity in bladder cancer: are we there yet?

Singla N, Ghandour RA, Raj GV.

Transl Androl Urol. 2019 Jul;8(Suppl 3):S236-S239. doi: 10.21037/tau.2019.01.10. No abstract available.

3.

A Structure-Activity Relationship Study of Bis-Benzamides as Inhibitors of Androgen Receptor-Coactivator Interaction.

Lee TK, Ravindranathan P, Sonavane R, Raj GV, Ahn JM.

Molecules. 2019 Jul 31;24(15). pii: E2783. doi: 10.3390/molecules24152783.

4.

Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate.

Costa DN, Goldberg K, Leon AD, Lotan Y, Xi Y, Aziz M, Freifeld Y, Margulis V, Raj G, Roehrborn CG, Hornberger B, Desai N, Bagrodia A, Francis F, Pedrosa I, Cadeddu JA.

Eur Urol Oncol. 2019 Jul;2(4):397-404. doi: 10.1016/j.euo.2018.08.022. Epub 2018 Sep 20.

PMID:
31277776
5.

DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway.

Kothari V, Goodwin JF, Zhao SG, Drake JM, Yin Y, Chang SL, Evans JR, Wilder-Romans K, Gabbara K, Dylgjeri E, Chou J, Sun G, Tomlins SA, Mehra R, Hege K, Filvaroff EH, Schaeffer EM, Karnes RJ, Quigley DA, Rathkopf DE, He HH, Speers C, Spratt DE, Gilbert LA, Ashworth A, Chinnaiyan AM, Raj GV, Knudsen KE, Feng FY.

Clin Cancer Res. 2019 Sep 15;25(18):5608-5622. doi: 10.1158/1078-0432.CCR-18-2387. Epub 2019 Jul 2.

PMID:
31266829
6.

Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate Cancer.

Sharp A, Porta N, Lambros MBK, Welti JC, Paschalis A, Raj GV, Plymate SP, de Bono JS.

J Clin Oncol. 2019 Aug 20;37(24):2182-2184. doi: 10.1200/JCO.19.01104. Epub 2019 Jul 2. No abstract available.

PMID:
31265359
7.

Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth.

Ta HQ, Whitworth H, Yin Y, Conaway M, Frierson HF Jr, Campbell MJ, Raj GV, Gioeli D.

Mol Cancer. 2019 Jun 28;18(1):113. doi: 10.1186/s12943-019-1039-6.

8.

Betatron radiation and emittance growth in plasma wakefield accelerators.

San Miguel Claveria P, Adli E, Amorim LD, An W, Clayton CE, Corde S, Gessner S, Hogan MJ, Joshi C, Kononenko O, Litos M, Lu W, Marsh KA, Mori WB, O'Shea B, Raj G, Storey D, Vafaei-Najafabadi N, White G, Xu X, Yakimenko V.

Philos Trans A Math Phys Eng Sci. 2019 Aug 12;377(2151):20180173. doi: 10.1098/rsta.2018.0173. Epub 2019 Jun 24.

9.

Producing multi-coloured bunches through beam-induced ionization injection in plasma wakefield accelerator.

Vafaei-Najafabadi N, Amorim LD, Adli E, An W, Clarke CI, Clayton CE, Corde S, Gessner S, Green SZ, Hogan MJ, Joshi C, Kononenko O, Lindstrøm CA, Litos M, Lu W, Marsh KA, Mori WB, San Miguel Claveria P, O'Shea B, Raj G, Storey D, White G, Xu X, Yakimenko V.

Philos Trans A Math Phys Eng Sci. 2019 Aug 12;377(2151):20180184. doi: 10.1098/rsta.2018.0184. Epub 2019 Jun 24.

PMID:
31230576
10.

Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase.

Lee CF, Dang A, Hernandez E, Pong RC, Chen B, Sonavane R, Raj G, Kapur P, Lin HY, Wu SR, Ko CJ, Lo UG, Lee HY, Hsieh JT, Lee MS.

Oncogene. 2019 Jul;38(28):5580-5598. doi: 10.1038/s41388-019-0833-3. Epub 2019 May 31.

PMID:
31152147
11.

EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer.

Viswanadhapalli S, Luo Y, Sareddy GR, Santhamma B, Zhou M, Li M, Ma S, Sonavane R, Pratap UP, Altwegg KA, Li X, Chang A, Chávez-Riveros A, Dileep KV, Zhang KYJ, Pan X, Murali R, Bajda M, Raj GV, Brenner AJ, Manthati V, Rao MK, Tekmal RR, Nair HB, Nickisch KJ, Vadlamudi RK.

Mol Cancer Ther. 2019 Aug;18(8):1341-1354. doi: 10.1158/1535-7163.MCT-18-1258. Epub 2019 May 29.

PMID:
31142661
12.

Association study of Apolipoprotein A5 gene (APOA5 gene) variant with the metabolic syndrome in local Pakistani population.

Fiaz M, Shaiq PA, Raj GK, Saqlain M, Mehmood A, Naqvi SMS, Cheung BK.

J Pak Med Assoc. 2019 Mar;69(3):301-305.

13.

Alignment-free method for DNA sequence clustering using Fuzzy integral similarity.

Saw AK, Raj G, Das M, Talukdar NC, Tripathy BC, Nandi S.

Sci Rep. 2019 Mar 6;9(1):3753. doi: 10.1038/s41598-019-40452-6.

14.

Investigational luteinizing hormone releasing hormone (LHRH) agonists and other hormonal agents in early stage clinical trials for prostate cancer.

Singla N, Ghandour RA, Raj GV.

Expert Opin Investig Drugs. 2019 Mar;28(3):249-259. doi: 10.1080/13543784.2019.1570130. Epub 2019 Jan 28. Review.

PMID:
30649971
15.

Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India.

Priyadarshini R, Raj GM, Kayal S, Ramesh A, Shewade DG.

J Clin Pharm Ther. 2019 Apr;44(2):188-196. doi: 10.1111/jcpt.12797. Epub 2019 Jan 13.

PMID:
30637776
16.

A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra.

Henry GH, Malewska A, Joseph DB, Malladi VS, Lee J, Torrealba J, Mauck RJ, Gahan JC, Raj GV, Roehrborn CG, Hon GC, MacConmara MP, Reese JC, Hutchinson RC, Vezina CM, Strand DW.

Cell Rep. 2018 Dec 18;25(12):3530-3542.e5. doi: 10.1016/j.celrep.2018.11.086.

17.

CRC7: Designing and Fabrication of Highly Precisive Robotic Arm With 3D Printing Technology for a Congenitally Missing Patient's Hand - A Clinical Case.

Raj G, Murugesan K, John P.

J Indian Prosthodont Soc. 2018 Oct;18(Suppl 1):S38. doi: 10.4103/0972-4052.244662. No abstract available.

18.

IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing.

Lo UG, Pong RC, Yang D, Gandee L, Hernandez E, Dang A, Lin CJ, Santoyo J, Ma S, Sonavane R, Huang J, Tseng SF, Moro L, Arbini AA, Kapur P, Raj GV, He D, Lai CH, Lin H, Hsieh JT.

Cancer Res. 2019 Mar 15;79(6):1098-1112. doi: 10.1158/0008-5472.CAN-18-2207. Epub 2018 Nov 30.

PMID:
30504123
19.

Protein-G-based lateral flow assay for rapid serodiagnosis of brucellosis in domesticated animals.

Manasa M, Revathi P, Chand MP, Maroudam V, Navaneetha P, Raj GD, Kishor PBK, De B, Rathnagiri P.

J Immunoassay Immunochem. 2019;40(2):149-158. doi: 10.1080/15321819.2018.1541803. Epub 2018 Nov 26.

PMID:
30477402
20.

Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response.

Shafi AA, Schiewer MJ, de Leeuw R, Dylgjeri E, McCue PA, Shah N, Gomella LG, Lallas CD, Trabulsi EJ, Centenera MM, Hickey TE, Butler LM, Raj G, Tilley WD, Cukierman E, Knudsen KE.

Eur Urol Oncol. 2018 Sep;1(4):325-337. doi: 10.1016/j.euo.2018.04.019. Epub 2018 Jun 6.

21.

PARP-1 regulates DNA repair factor availability.

Schiewer MJ, Mandigo AC, Gordon N, Huang F, Gaur S, de Leeuw R, Zhao SG, Evans J, Han S, Parsons T, Birbe R, McCue P, McNair C, Chand SN, Cendon-Florez Y, Gallagher P, McCann JJ, Poudel Neupane N, Shafi AA, Dylgjeri E, Brand LJ, Visakorpi T, Raj GV, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Kelly WK, Leiby BE, Knudsen B, Feng FY, Knudsen KE.

EMBO Mol Med. 2018 Dec;10(12). pii: e8816. doi: 10.15252/emmm.201708816.

22.

Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy.

Freifeld Y, Xi Y, Passoni N, Woldu S, Hornberger B, Goldberg K, Bagrodia A, Raj G, Margulis V, Cadeddu JA, Lotan Y, Francis F, Pedrosa I, G Roehrborn C, Costa DN.

Urol Oncol. 2019 Jan;37(1):57-62. doi: 10.1016/j.urolonc.2018.10.009. Epub 2018 Nov 13.

PMID:
30446460
23.

Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients.

Raj GM, Mathaiyan J, Wyawahare M, Priyadarshini R.

Drug Metab Pers Ther. 2018 Dec 19;33(4):175-185. doi: 10.1515/dmpt-2018-0030.

PMID:
30433870
24.

Bioassay guided fractionation of Cyclea peltata using in vitro RAW 264.7 cell culture, antioxidant assays and isolation of bioactive compound tetrandrine.

Shine VJ, Anuja GI, Suja SR, Raj G, Latha PG.

J Ayurveda Integr Med. 2018 Oct 23. pii: S0975-9476(17)30611-3. doi: 10.1016/j.jaim.2018.05.009. [Epub ahead of print]

25.

From "Glivec®" to "Prevnar 13®": How strong is the Indian drug patenting system?

Raj GM.

Perspect Clin Res. 2018 Oct-Dec;9(4):187-188. doi: 10.4103/picr.PICR_102_18. No abstract available.

26.

Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Wang S, Ekoue DN, Raj GV, Kittler R.

Cancer Lett. 2018 Dec 1;438:86-96. doi: 10.1016/j.canlet.2018.09.010. Epub 2018 Sep 11. Review.

PMID:
30217566
27.

Role of cell proliferation and vascularity in malignant transformation of potentially malignant disorders.

Sheelam S, Reddy SP, Kulkarni PG, Nandan S, Keerthi M, Raj GS.

J Oral Maxillofac Pathol. 2018 May-Aug;22(2):281. doi: 10.4103/jomfp.JOMFP_182_17.

28.

Alternative splicing in prostate cancer.

Paschalis A, Sharp A, Welti JC, Neeb A, Raj GV, Luo J, Plymate SR, de Bono JS.

Nat Rev Clin Oncol. 2018 Nov;15(11):663-675. doi: 10.1038/s41571-018-0085-0. Review.

PMID:
30135575
29.

A patient-derived explant (PDE) model of hormone-dependent cancer.

Centenera MM, Hickey TE, Jindal S, Ryan NK, Ravindranathan P, Mohammed H, Robinson JL, Schiewer MJ, Ma S, Kapur P, Sutherland PD, Hoffmann CE, Roehrborn CG, Gomella LG, Carroll JS, Birrell SN, Knudsen KE, Raj GV, Butler LM, Tilley WD.

Mol Oncol. 2018 Sep;12(9):1608-1622. doi: 10.1002/1878-0261.12354. Epub 2018 Aug 16.

30.

Cetirizine-Induced Fixed Drug Eruption.

Gopal S, Gnanasegaran S, Raj GM, Murugesan S, Adhimoolam M.

J Res Pharm Pract. 2018 Apr-Jun;7(2):111-114. doi: 10.4103/jrpp.JRPP_17_99.

31.

Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.

Regan Anderson TM, Ma S, Perez Kerkvliet C, Peng Y, Helle TM, Krutilina RI, Raj GV, Cidlowski JA, Ostrander JH, Schwertfeger KL, Seagroves TN, Lange CA.

Mol Cancer Res. 2018 Nov;16(11):1761-1772. doi: 10.1158/1541-7786.MCR-18-0410. Epub 2018 Jul 10.

PMID:
29991529
32.

Mechanical and Crystallographic Analysis of Cholesterol Crystals Puncturing Biological Membranes.

Al-Handawi MB, Commins P, Karothu DP, Raj G, Li L, Naumov P.

Chemistry. 2018 Aug 6;24(44):11493-11497. doi: 10.1002/chem.201802251. Epub 2018 Jul 10.

PMID:
29877594
33.

Turning on Solid-State Fluorescence with Light.

Schramm S, Karothu DP, Raj G, Laptenok SP, Solntsev KM, Naumov P.

Angew Chem Int Ed Engl. 2018 Jul 20;57(30):9538-9542. doi: 10.1002/anie.201803424. Epub 2018 Jun 25.

PMID:
29855133
34.

Interference of citrate-stabilized gold nanoparticles with β2-microglobulin oligomeric association.

Cantarutti C, Raj G, Fogolari F, Giorgetti S, Corazza A, Bellotti V, Naumov P, Esposito G.

Chem Commun (Camb). 2018 May 24;54(43):5422-5425. doi: 10.1039/c8cc01053f.

PMID:
29737327
35.

Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC).

Welti J, Sharp A, Yuan W, Dolling D, Nava Rodrigues D, Figueiredo I, Gil V, Neeb A, Clarke M, Seed G, Crespo M, Sumanasuriya S, Ning J, Knight E, Francis JC, Hughes A, Halsey WS, Paschalis A, Mani RS, Raj GV, Plymate SR, Carreira S, Boysen G, Chinnaiyan AM, Swain A, de Bono JS; International SU2C/PCF Prostate Cancer Dream Team.

Clin Cancer Res. 2018 Jul 1;24(13):3149-3162. doi: 10.1158/1078-0432.CCR-17-3571. Epub 2018 Mar 19.

36.

Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer.

Nassar ZD, Aref AT, Miladinovic D, Mah CY, Raj GV, Hoy AJ, Butler LM.

BJU Int. 2018 May;121 Suppl 3:9-21. doi: 10.1111/bju.14173. Epub 2018 Mar 26. Review.

37.

A new class of agents for estrogen-receptor-positive breast cancer.

Ekoue DN, Unni N, Raj GV.

Expert Rev Clin Pharmacol. 2018 Apr;11(4):325-328. doi: 10.1080/17512433.2018.1439736. No abstract available.

PMID:
29439601
38.

Point of Care Tuberculosis Sero-Diagnosis Kit for Wild Animals: Combination of Proteins for Improving the Diagnostic Sensitivity and Specificity.

Veerasami M, Venkataraman K, Karuppannan C, Shanmugam AA, Prudhvi MC, Holder T, Rathnagiri P, Arunmozhivarman K, Raj GD, Vordermeier M, Mohana Subramanian B.

Indian J Microbiol. 2018 Mar;58(1):81-92. doi: 10.1007/s12088-017-0688-7. Epub 2017 Nov 11.

39.

Electrical Impedance Measurements of Biological Cells in Response to External Stimuli.

Mansoorifar A, Koklu A, Ma S, Raj GV, Beskok A.

Anal Chem. 2018 Apr 3;90(7):4320-4327. doi: 10.1021/acs.analchem.7b05392. Epub 2018 Feb 14.

PMID:
29402081
40.

BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer.

Li X, Baek G, Ramanand SG, Sharp A, Gao Y, Yuan W, Welti J, Rodrigues DN, Dolling D, Figueiredo I, Sumanasuriya S, Crespo M, Aslam A, Li R, Yin Y, Mukherjee B, Kanchwala M, Hughes AM, Halsey WS, Chiang CM, Xing C, Raj GV, Burma S, de Bono J, Mani RS.

Cell Rep. 2018 Jan 16;22(3):796-808. doi: 10.1016/j.celrep.2017.12.078.

41.

Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis.

Woldu SL, Ci B, Hutchinson RC, Krabbe LM, Singla N, Passoni NM, Clinton TN, Raj GV, Miller DS, Sagalowsky AI, Lotan Y, Xie Y, Margulis V, Bagrodia A.

Urol Oncol. 2018 Apr;36(4):159.e7-159.e17. doi: 10.1016/j.urolonc.2017.12.001. Epub 2017 Dec 26.

PMID:
29288008
42.

Commentary to "Patients not patents: drug research and development as a public enterprise".

Raj GM.

Eur J Clin Invest. 2018 Feb;48(2). doi: 10.1111/eci.12882. Epub 2018 Jan 17. No abstract available.

PMID:
29281851
43.

Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting.

Luo J, Attard G, Balk SP, Bevan C, Burnstein K, Cato L, Cherkasov A, De Bono JS, Dong Y, Gao AC, Gleave M, Heemers H, Kanayama M, Kittler R, Lang JM, Lee RJ, Logothetis CJ, Matusik R, Plymate S, Sawyers CL, Selth LA, Soule H, Tilley W, Weigel NL, Zoubeidi A, Dehm SM, Raj GV.

Eur Urol. 2018 May;73(5):715-723. doi: 10.1016/j.eururo.2017.11.038. Epub 2017 Dec 16. Review.

44.

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG.

J Clin Oncol. 2018 Feb 1;36(4):414-424. doi: 10.1200/JCO.2017.74.1173. Epub 2017 Dec 13. Review.

45.

Tissue-based biomarkers in prostate cancer.

Clinton TN, Bagrodia A, Lotan Y, Margulis V, Raj GV, Woldu SL.

Expert Rev Precis Med Drug Dev. 2017;2(5):249-260. doi: 10.1080/23808993.2017.1372687. Epub 2017 Sep 5.

46.

Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses.

Woldu SL, Aydin AM, Rao AV, Hutchinson RC, Singla N, Clinton TN, Krabbe LM, Passoni NM, Raj GV, Miller DS, Amatruda JF, Sagalowsky AI, Lotan Y, Arriaga Y, Margulis V, Bagrodia A.

Urology. 2018 Feb;112:103-111. doi: 10.1016/j.urology.2017.08.059. Epub 2017 Dec 6.

PMID:
29079210
47.

Incorporating Oxygen-Enhanced MRI into Multi-Parametric Assessment of Human Prostate Cancer.

Zhou H, Hallac RR, Yuan Q, Ding Y, Zhang Z, Xie XJ, Francis F, Roehrborn CG, Sims RD, Costa DN, Raj GV, Mason RP.

Diagnostics (Basel). 2017 Aug 24;7(3). pii: E48. doi: 10.3390/diagnostics7030048.

48.

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers.

Raj GV, Sareddy GR, Ma S, Lee TK, Viswanadhapalli S, Li R, Liu X, Murakami S, Chen CC, Lee WR, Mann M, Krishnan SR, Manandhar B, Gonugunta VK, Strand D, Tekmal RR, Ahn JM, Vadlamudi RK.

Elife. 2017 Aug 8;6. pii: e26857. doi: 10.7554/eLife.26857.

49.

Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer Irradiation.

Yin Y, Li R, Xu K, Ding S, Li J, Baek G, Ramanand SG, Ding S, Liu Z, Gao Y, Kanchwala MS, Li X, Hutchinson R, Liu X, Woldu SL, Xing C, Desai NB, Feng FY, Burma S, de Bono JS, Dehm SM, Mani RS, Chen BPC, Raj GV.

Cancer Res. 2017 Sep 15;77(18):4745-4754. doi: 10.1158/0008-5472.CAN-17-0164. Epub 2017 Jul 28.

50.

Adherence to Diabetes Dietary Guidelines Assessed Using a Validated Questionnaire Predicts Glucose Control in Adults With Type 2 Diabetes.

Raj GD, Hashemi Z, Soria Contreras DC, Babwik S, Maxwell D, Bell RC, Chan CB.

Can J Diabetes. 2018 Feb;42(1):78-87. doi: 10.1016/j.jcjd.2017.04.006. Epub 2017 Jun 22.

PMID:
28648765

Supplemental Content

Support Center